Cyp2d6 Gene - Infectious Diseases

Relevant Publications

The potential Role of CYP2D6*10(c.100 C>T) Gene Polymorphism in Kidney Injury of Patients with Hypertension Complicated with Non-Elevated Cystatin C.

Issue Release: 2024

Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis.

Issue Release: 2024

Pharmacokinetics and Safety of Atogepant Co-administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study.

Issue Release: 2024

Exploring CYP2D6 polymorphisms and angiotensin receptor blocker response in the Bai hypertensive population.

Issue Release: 2024

Genetic prediction of antihyperglycemic drug targets and risk of epilepsy: a mendelian randomisation study.

Issue Release: 2024

Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients.

Issue Release: 2024

Novel Independent Trans- and Cis-Genetic Variants Associated with CYP2D6 Expression and Activity in Human Livers.

Issue Release: 2024

Genome-wide analysis of hepatic DNA methylation reveals impact of epigenetic aging on xenobiotic metabolism and transport genes in an aged mouse model.

Issue Release: 2024

Novel Tree Shrew Cytochrome P450 2Ds (CYP2D8a and CYP2D8b) Are Functional Drug-Metabolizing Enzymes that Metabolize Bufuralol and Dextromethorphan.

Issue Release: 2024

Effects of gene polymorphism on plasma concentration and therapeutic effect of olanzapine.

Issue Release: 2024

Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.

Issue Release: 2024

Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea.

Issue Release: 2024

ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.

Issue Release: 2024

Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics.

Issue Release: 2024

Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response.

Issue Release: 2024

Cadmium causes spleen toxicity in chickens by regulating mitochondrial unfolded protein response and nuclear receptors response.

Issue Release: 2024

Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid.

Issue Release: 2024

Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study.

Issue Release: 2024

Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis.

Issue Release: 2024

Prevalence of CYP2D6 structural variation in large retrospective study.

Issue Release: 2024

What Are Some Examples of Inherited Immunity?

How Can Herpes Be Prevented?

Which Microorganisms Commonly Colonize Humans?

What are Artemisinin-Based Combination Therapies (ACTs)?

Is There a Vaccine for Yellow Fever?

How Can Adverse Effects be Minimized?

What Are Autoimmune Diseases?

What are Viruses?

How Do Antipyretics Affect the Course of Infectious Diseases?

What Infections Can Be Diagnosed Using Throat Swabs?

Partnered Content Networks

Relevant Topics